The components of basic and diluted earnings per share are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
(in thousands, except per share data) |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(9,288 |
) |
|
$ |
(10,903 |
) |
|
$ |
(19,421 |
) |
|
$ |
(25,960 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding, basic |
|
|
4,795 |
|
|
|
2,777 |
|
|
|
4,708 |
|
|
|
2,767 |
|
Dilutive effect of restricted stock units (1) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Dilutive effect of stock options |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Dilutive effect of 2025 Warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Weighted average common shares outstanding, diluted |
|
|
4,795 |
|
|
|
2,777 |
|
|
|
4,708 |
|
|
|
2,767 |
|
Net loss per share, basic |
|
$ |
(1.94 |
) |
|
$ |
(3.93 |
) |
|
$ |
(4.13 |
) |
|
$ |
(9.38 |
) |
Net loss per share, diluted |
|
$ |
(1.94 |
) |
|
$ |
(3.93 |
) |
|
$ |
(4.13 |
) |
|
$ |
(9.38 |
) |
Anti-dilutive securities excluded from diluted loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Anti-dilutive restricted stock units (1) |
|
|
459 |
|
|
|
64 |
|
|
|
359 |
|
|
|
65 |
|
Anti-dilutive stock options |
|
|
53 |
|
|
|
78 |
|
|
|
57 |
|
|
|
80 |
|
Anti-dilutive 2025 Warrants |
|
|
143 |
|
|
|
— |
|
|
|
143 |
|
|
|
— |
|
Anti-dilutive warrants |
|
|
145 |
|
|
|
145 |
|
|
|
145 |
|
|
|
145 |
|
Anti-dilutive performance-based restricted stock units |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
(1) Due to the net loss during each of the three and six months ended June 30, 2026 and 2025, no dilutive securities were included in the calculation of diluted loss per share because they would have been anti-dilutive.
|